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Chapter 1 Introduction 
1.2 Endolysosomal and Secretory Pathways in Mammalian Cells 
Endocytosis occurs by a number of different mechanisms that fall into two broad 
categories, phagocytosis and pinocytosis (Figure 1.1). Phagocytosis involves the uptake 
of large particles, whilst pinocytosis occurs when cells take up fluid and solutes (Conner 
and Schmid, 2003). There are at least four mechanisms of pinocytosis: macropinocytosis 
(reviewed by Swanson and Watts, 1995), clathrin-mediated endocytosis (reviewed by 
Mousavi et aI, 2004), caveolae mediated endocytosis (reviewed by Pelkmans and 
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Fig 1.1. The endocytic pathways in mammalian cells. (Conner and Schmid, 2003) 
1.2.1 Phagocytosis 
Phagocytosis in mammalian cells is generally restricted to specialized cells, including 
macrophages, monocytes and neutrophils (Conner and Schmid, 2003). The function of 
these cells is to ingest and clear large pathogens (Allen and Aderem, 1996). 
Internalization begins when specific surface receptors on a phagocyte interact with 
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Chapter 2 P. Jalciparum Drug Sensitivity and Parasite Morphology Changes 
parasites. Additionally, their food vacuoles appeared reduced m SIze and hemozoin 
crystals were barely visible. 
CON AQ AQ 
CQ H H 
/ 
MQ Q Q 
Fig 2.2. Giemsa stains of 307 P. Jalciparnm parasites. Parasites were untreated (CON), incubated 
with amodiaquine (AQ), chloroquine (CQ), halofantrine (H), mefloquine (MQ) or quinine (Q) at 
a concentration 5 times the ICso value for each drug for 8 hours. Thin blood smears were then 
prepared and stained with Giemsa. Slides were viewed under a light microscope. Arrows indicate 
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Chapter 3 Hemoglobin Uptake and Accumulation in P. falciparum 3D7 
3.2.2 Hemoglobin Levels in 3D7 P. falciparum Treated with Quinoline Anti-Malarials 
for 8 Hours 
The incubation time of P.falciparum parasites with 102 nM AQ, 137 nM CQ, 27 nM H, 
156 nM MQ and 665 nM Q, was expanded to 8 hours. Apart from AQ-treated parasites, 
this had the effect of amplifying the results obtained following a 6 hour incubation 
period. 
SE 
Con AQ CQ H MQ 
Fig 3.1. Representative Western Blot image showing hemoglobin levels in parasites treated with 
quinoline anti-malarials for 8 hours. Parasite cultures were untreated (control, Con), incubated 
with 102 nM amodiaquine (AQ), 137 nM chloroquine (CQ), 27 nM halofantrine (H), 156 nM 
mefloquine (MQ) or 665 nM quinine (Q) .. 
Concentration Mean Band Intensity 
Sample (nM) Relative to Control (%) N 
±SD 
Control 100.0 ± 9.0 6 
AQ 102 95.2 ± 9.4 6 
CQ 137 185.9 ± 48.4 6 
H 27 16.2 ± 5.2 3 
MQ 156 16.9 ± 2.1 3 
Q 665 35.6 ±10.2 3 
Table 3.2. Western Blot hemoglobin intensities of parasite lysate bands following drug-treatment 
of parasites for 8 hours. Parasite cultures were untreated (Control), incubated 102 nM 
amodiaquine (AQ), 137 nM chloroquine (CQ), 27 nM halofantrine (H), 156 nM mefloquine 
(MQ) or 665 nM quinine (Q). Intensities of hemoglobin bands were determined using the 
histogram function of Adobe Photoshop (version 7.0) software. The intensities were normalized 





























Chapter 3 Hemoglobin Uptake and Accumulation in P. Jalciparum 3D7 
Treatment with CQ for 8 hours resulted in an increase in hemoglobin levels (P = 0.0212). 
Treatment with H, MQ or Q for 8 hours resulted in a further decrease in hemoglobin 
levels relative to the controls (P = 0.0001, P <0.0001, P = 0.001 for H, MQ and Q-treated 
parasites respectively) (Table 3.2, Figures 3.1 and 3.2 B). 
Although treatment with AQ for 8 hours caused a slight reduction in hemoglobin levels 
relative to those in control parasites (Table 3.2, Figures 3.1 and 3.2 B), the change was 
however not statistically significant at the 95 % CI (P = 0.4780). 
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Con AQ CQ H MQ Q Con AQ CQ H MQ 
A B 
Fig 3.2 Hemoglobin levels in drug-treated parasites. Parasite cultures were untreated (control, 
Con), incubated with 102 nM amodiaquine (AQ), 137 nM chloroquine (CQ), 27 nM halofantrine 
(H), 156 nM mefloquine (MQ) or 665 nM quinine (Q) for 6 hours (A) or 8 hours (B). Intensities 
of hemoglobin bands on Western Blots were determined using the histogram function of Adobe 
Photoshop (version 7.0) software. The intensities were normalized to control intensities. Error 












Chapter 3 Hemoglobin Uptake and Accumulation in P. Jalciparum 3D7 
3.2.3 Hemoglobin Levels in 3D7 P. Jalciparum Treated with Quinoline Anti-Malarials 
and Protease Inhibitors 
Using hemoglobin levels in parasites as a measure of endocytosis is confounded by the 
fact that hemoglobin is rapidly digested in the food vacuole. Therefore in order to 
eliminate the contribution of digestion and to obtain a more accurate measure of the 
effects of the anti-malarial drugs on hemoglobin endocytosis and vesicular trafficking 
alone, protease inhibitors (PIs) ALLN and E64 were included during drug treatments. 
These inhibitors have previously been found to inhibit hemoglobin digestion in malarial 
parasites (Francis et aI, 1997). Western Blotting Assays were conducted using cultures 
treated with the quinoline anti-malarial drugs at concentrations 5 times their ICso values 
or with drug and PIs . 
• 
Con Con (PI) MQ MQ (PI) Q Q (PI) H H (PI) AQ 
•• T • 
Con Con (PI) CQ CQ (PI) 
Fig 3.3. Representative Western Blot images showing hemoglobin levels in parasites. Parasite 
cultures were untreated (control, Con), incubated with 102 nM amodiaquine (AQ), 137 nM 
chloroquine (CQ), 27 nM halofantrine (H), 156 nM mefloquine (MQ), or 665 nM quinine (Q) for 
8 hours. Cultures were treated with drug alone, or drug and protease inhibitors, ALLN and E64 















































Chapter 3 Hemoglobin Uptake and Accumulation in P. Jalciparum 3D7 
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Fig 3.4. Hemoglobin levels in parasites, Parasite cultures were untreated (control, Con), 
incubated with 102 nM amodiaquine (AQ), 137 nM chloroquine (CQ), 27 nM halofantrine (H), 
156 nM mefloquine (MQ), or 665 nM quinine (Q) (figures A to E respectively), Cultures were 
treated with drug alone, or drug and protease inhibitors, 40 /-LM ALLN and E64 (PI), Error bars 
indicate standard error. * Statistically significant change from controls (95% CI), either untreated 
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Chapter 4 HRP Uptake and Accumulation in P. Jalciparum 
relative to times used during Western Blot assays as a longer period of time is required 
for parasites to endocytose sufficient HRP to be detectable. Following incubation, 
parasites were released from RBCs by saponin treatment and washed in order to remove 
extraparasitic HRP. Parasites were lysed and o-phenylenediamine (OPD, colorimetric 
HRP substrate) was added. The absorbance was then measured at 450 nm usmg a 
spectrophotometer. 
All of the drugs caused a reduction in HRP internalization (Figure 4.1, Table 4.1). The 
changes were statistically significant at the 95 % CI (AQ: P<O.OOOI, CQ: P = 0.0055, H: 
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Con AQ CQ H MQ Q 
Fig 4.1. HRP levels in P. Jalciparum 3D7, measured as Absorbance at 450 nm after OPD (HRP 
substrate) addition. Parasites were allowed to invade RBCs preloaded with HRP. They were then 
left untreated (control), or treated with 102 nM amodiaquine (AQ), 137 nM chloroquine (CQ), 27 
nM halofantrine (H), 156 oM mefloquine (MQ) or 665 nM quinine (Q) for 10 hours. Following 
incubation, parasites were released from RBCs, washed repeatedly and lysed. Error bars indicate 
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Chapter 5 Hemoglobin Transport Vesicles and Food Vacuoles in P.falciparum 
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Fig 5.1. Hemoglobin transport vesicles in parasites. Parasite cultures were left untreated (control, 
Con), incubated with 102 nM amodiaquine (AQ), 137 oM chloroquine (CQ), 27 oM halofantrine 
(H), 156 nM mefloquine (MQ) or 665 nM quinine (Q). Parasites were fixed onto slides and 
incubated with anti-hemoglobin antiserum, followed by fluorescentiy-labeled secondary antibody. 
Transport vesicles were counted under a fluorescent microscope. Error bars indicate standard 
error. * Statistically significant change from control (95% CI). 
5.2.2 Hemoglobin Levels in Parasite Food Vacuoles 
Sample Concentration Food Vacuole Fluorescent N 
(nM) Intensity ± SO 
Control 214.7 ± 37.3 100 
AQ 102 217.1±61.0 100 
CQ 137 223.3 ± 41.1 100 
H 27 172.4 ± 72.1 100 
MQ 156 159.4 ± 66.0 100 
Q 665 178.1 ± 68.2 100 
Table 5.2. Mean fluorescent intensity (arbitrary units) in parasite food vacuoles ± standard 
deviation (SO). Parasites were untreated (control), incubated with 102 nM amodiaquine (AQ), 
137 nM chloroquine (CQ), 27 oM halofantrine (H), 156 nM mefloquine (MQ) or 665 oM quinine 
(Q) for 5-6 hours. Parasites were fixed onto slides and incubated with anti-hemoglobin antiserum, 
followed by fluorescentiy-labeled secondary antibody. Fluorescence intensity in parasite food 
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5.2. Fluorescence In food vacuoles. Parasite cultures were 
left untreated (control, CON), incubated with 102 nM uWCV"'U'i (AQ), 137 nM 
27 nM (H), 156 nM (Q) for 5-6 hours. 
Parasites were fixed onto slides and incubated with followed a 
antibody. Parasites were then examined under a fluorescent 
and the fluorescent intensities of food vacuoles were 
determined using the function of Adobe Error bars indicate standard error. 
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Chapter 5 Hemoglobin Transport Vesicles and Food Vacuoles in P.falciparum 
I 
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(A) Con 1 (B) Con 1 
(A) CQ 1 (B) CQ 1 
(A) AQ 1 (B) AQ 1 
(A) MQ 1 (B) MQ 1 
(A) Q 1 (B) Q 1 
• , .. . , ,...;.. .. 
(A) Con 2 
(A) CQ 2 
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~~. 
(B) Con 2 
(B) CQ 2 
(B) AQ 2 
(B) MQ 2 
(B) HI 
Fig. 5.3. Subcellular localization of hemoglobin by immunofluorescence. Parasites from control 
(Con), CQ-treated (CQ), AQ-treated (AQ), MQ-treated (MQ), Q-treated (Q), and H-treated (H) 
cultures. Left-handed panels (A), fluorescent images; right-handed panels (B), phase-contrast 
images. The hemazoin crystal marks the position of the food vacuole (white arrows). Transport 
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Chapter 6 FITC-Dextran Uptake, Accumulation and Efflux from D. discoideum 
1000 
900 * * * 




Con AO co H MO 0 Con AO co H MQ Q 
B 
Fig 6.4. Efflux from D. discoideum cells preloaded with FITC-Dextran. Preloaded amoeboid cells 
were untreated (control, Con), or incubated with 20 )..lM amodiaquine (AQ), chloroquine (CQ), 
halofantrine (H), mefloquine (MQ) or quinine (Q) for 60 minutes (A) or 90 minutes (B). 
Supernatant was retrieved and efflux was measured as fluorescence [exitation (ex) 470 nm, 
emission (em) 520 nm]. Error bars indicate standard error. *Statistically significant change from 
control (95% CI). 
Following a 90 minute incubation period, Dictyostelium cells treated with 20 11M AQ or 
CQ again did not show a statistically significant change in tracer molecule efflux relative 
to the controls (P = 0.6367 and P = 0.8587 respectively) (Table 6.2, Figure 6.4 B). Cells 
treated with MQ, H or Q for 90 minutes demonstrated further efflux of FITC-Dextran 




D. discoideum has an unusual endolysosomal pathway in that a state of equilibrium is 











Chapter 6 FITC-Dextran Uptake, Accumulation and Efflux from D. discoideum 
indigestible tracer molecules such as FITC-Dextran would not accumulate in untreated 
cells (unlike HRP in malarial parasites) but would travel through the endolysosomal 
pathway and be shunted out of the cell. Intracellular FITC-Dextran levels in D. 
discoideum are thus reflective of endocytosis, vesicular trafficking, processing and 
docking, as well as of exocytosis. Treatment with 5 to 20 ).lM CQ for 90 minutes was 
found to cause a small increase in FITC-Dextran internalization and accumulation in 
amoeboid D. discoideum cells. CQ has previously been found to influence the secretory 
pathway in mammalian cells (Smith and Jarret, 1982; Moore et aI, 1983; Schrader-
Fischer and Paganetti, 1996; Davis and Mecham, 1998) from a concentration of 100 ).lM. 
Although CQ was found to disrupt secretory pathways in mammalian cells at higher 
concentrations, it is possible that treatment of D. discoideum with 20 ).lM CQ is sufficient 
to cause the drug to accumulate in intracellular acidic compartments. This may cause the 
pH to rise to a certain extent, disrupting exocytosis and resulting in pinosome 
accumulation and a small increase in intracellular tracer molecule levels. Alternatively, 
CQ may cause a slight increase in FITC-Dextran concentration by impeding pinosome 
processing. Disruption of vesicular trafficking or fusion events would cause a reduction 
in processes such as exocytosis that are further along the pathway, therefore, inhibition of 
pinosome processing may also cause pinosome build-up and thus tracer molecule 
accumulation in D. discoideum cells. 
CQ accumulation in malarial parasites is partially dependent on its high affinity binding 
to FP (Aikawa, 1972; Fitch et aI, 1974; Krogstad et aI , 1985; Hawley et aI, 1996), 
therefore CQ would accumulate to a lesser degree in acidic compartments in the absence 
of large amounts of FP. CQ is thus likely to have greater toxicity at lower concentrations 
in malarial parasites than in other organisms due to the presence of large amounts of FP. 
Additionally, CQ may inhibit hemoglobin digestion by disrupting proteolytic enzymatic 
function in malarial parasites and in this way disrupt vesicular docking (Chapters 3-5). As 
hemoglobin is absent in D. discoideum, this potential mechanism of CQ disruption of 



































Chapter 6 FITC-Dextran Uptake, Accumulation and Efflux from D. discoideum 
As mentioned in the previous section, a state of equilibrium is reached between rapid 
endocytosis and exocytosis in D. discoideum. Therefore, FITC-Dextran levels in these 
cells are likely to not only be indicative of endocytosis, but also of vesicular processing 
and exocytosis. Therefore, an exocytosis assay was conducted in order to determine the 
contribution of this process to reduced tracer molecule levels in MQ and H-treated cells. 
Treatment with 20 I-lM MQ or H was found to induce tracer molecule efflux following 
the addition of these drugs to D. discoideum cells that were preloaded with FlTC-
Dextran. This is not surprising given that the addition of 7.5 mM caffeine, also an 
effective endocytosis blocker, to D. discoideum cells preloaded with FlTC-Dextran was 
found to cause efflux of 20-25 % of tracer molecules (Aubry et aI, 1997). 
In MQ and H-treated cells, efflux may partially contribute to the observed reduction in 
tracer molecule accumulation that was at first attributed to a block in pinocytosis. It is 
thus possible that drug-induced efflux is responsible for a small extent of the reduction in 
hemoglobin and HRP levels observed in P. Jalciparum 3D7 parasites treated with MQ or 
H (Chapters 4 and 5). 
6.3.3 Quinine 
Treatment with 2.5 to 20 I-lM Q was found to only cause a slight, but not statistically 
significant, reduction in FITC-Dextran internalization and accumulation following a 90 
minute incubation period. It is thus possible that Q requires the presence of FP for its 
mechanism of action. Q was found to inhibit endocytosis in P. Jalciparum (Chapters 3-5), 
an organism in which FP is abundant. However, Q was found to effectively inhibit 
endocytosis in parasites that had invaded RBCs preloaded with HRP (Chapter 4), even 
though intracellular FP levels were probably reduced during this assay. Therefore, the 
action of Q may be enhanced by FP, but not dependent on the presence of this molecule. 











Chapter 6 FITC-Dextran Uptake, Accumulation and Efflux from D. discoideum 
drug may interact with a molecule or process that is essential to endocytosis in P. 
Jalciparum, but is not present or is dissimilar in other organisms. 
Treatment with 20 !lM Q for 60 and 90 minute periods was found to induce tracer 
molecule efflux following the addition of the drug to D. discoideum cells preloaded with 
FITC-Dextran. The slight reduction observed in tracer molecule accumulation in cells 
following Q-treatment may therefore be due to efflux. This finding supports the 
hypothesis mentioned in the previous section that efflux may only be partially responsible 
for reduced intracellular levels of FITC-Dextran in D. discoideum cells and reduced 
levels of HRP and hemoglobin in P. jalciparum cells following treatment with MQ or H. 
Intracellular levels of FITC-Dextran were only slightly reduced in Q-treated cells, but 
levels of efflux were similar in MQ, Hand Q-treated cells. Therefore, in MQ and H-
treated cells, efflux can at most account for the degree of the reduction in tracer molecule 
levels that was seen in Q-treated cells in the FITC-Dextran uptake and accumulation 
assays. It is furthermore possible that drug-induced efflux is responsible for a small 
extent of the reduction in hemoglobin and HRP levels observed in P. Jalciparum 3D7 
parasites treated with Q (Chapters 4 and 5). 
6.3.4 Amodiaquine 
Treatment with 20 !lM AQ for 90 minutes caused variable changes in FITC-Dextran 
accumulation in D. discoideum cells relative to the controls. Tracer molecule levels were 
sometimes raised but reduced at other times. AQ-treatment may result in the inhibition of 
pinocytosis and vesicular processing concurrently, inhibiting one or the other to varying 
degrees at different times. Additionally, as CQ has been found to disrupt the secretory 
pathway in mammalian cells (Smith and Jarret, 1982; Moore et aI, 1983; Schrader-
Fischer and Paganetti, 1996; Davis and Mecham, 1998) and possibly D. disocideum, AQ 
may have the same affect in these organisms. Treatment of P. Jalciparum 3D7 with AQ 
also resulted in variable changes in hemoglobin build-up (Chapter 3). AQ-treatment 











Chapter 6 FITC-Dextran Uptake, Accumulation and Efflux from D. discoideum 
of transport vesicles in the cytoplasm of P. Jalciparum (Chapter 5). These findings 
suggest that AQ inhibits endocytosis and vesicular docking and may disrupt exocytosis in 
P. Jalciparum, and therefore support the above hypothesis that AQ has the same effect in 
D. discoideum cells. Treatment with 20 /lM AQ did not cause a significant change in 
FITC-Dextran efflux from Dictyostelium cells. One would not expect to see a reduction 
in FITC-Dextran efflux if endocytosis and vesicular docking and/or exocytosis were 












The Effect of Quinoline Anti-Malarials on Horseradish Peroxidase 
Uptake and Accumulation in A549 Cells 
7.1 Introduction 
It has been demonstrated that AQ, CQ, H, MQ and Q influence the endolysosomal 
pathway in P. Jalciparum 3D7 cells (Chapters 3-5). Additionally CQ, H, MQ, Q and 
possibly AQ were found to affect endocytosis, vesicular processing and/or exocytosis in 
D. discoideum (Chapter 6). Previous studies have found that MQ disrupts the phagocytic 
pathway in mammalian cells (Labro and Babin-Chevaye, 1988), whilst CQ influences the 
secretory pathway (Smith and Jarret, 1982; Moore et ai, 1983; Schrader-Fischer and 
Paganetti, 1996; Davis and Mecham, 1998). It is thus possible that the quinoline anti-
malarials influence endocytosis, vesicular processing and/or secretion in mammalian 
cells. As the endolysosomal and secretory pathways are well understood in mammalian 
cells, but poorly understood in Plasmodium, the precise effect of these drugs on these 
processes may be studied with greater clarity using mammalian cells. MQ and H have 
been found to inhibit endocytosis in P. Jalciparum and D. discoideum, therefore it is 
possible that these drugs inhibit endocytosis in a broad range of organisms. Knowledge of 
their effects may thus prove useful for cell biological studies in which the inhibition of 
endocytosis is specifically required. Additionally, side-effects may be revealed that could 
be of clinical relevance. Therefore, HRP internalization assays were conducted using 
human pulmonary cancer cells (A549) cells. 
FP has previously been found to playa role in CQ accumulation (Aikawa, 1972; Fitch et 
ai, 1974; Krogstad et ai, 1985; Hawley et ai, 1996) and possibly CQ disruption of 
membrane function (Hoppe et ai, 2004; Fitch, 2004) in malarial parasites. Therefore, as 
the action of one or more of the other drugs may be affected by the presence of FP, 











Chapter 7 HRP Uptake and Accumulation in A549 Cells 
7.2 Results 
A549 cells were allowed to attach to the surface of 24 well plates. They were then 
incubated in HRP-containing medium and 20 ).lM of each drug alone or drug and RBC 
lysate for 150 minutes. Drugs were added at this concentration as treatment with 20 ).lM 
MQ, Hand CQ (as well as lower concentrations of each drug) were found to influence 
the endolysosmal pathway in D. discoideum (Chapter 6). The incubation time for this 
assay was longer than the times used during experimentation with D. discoideum as 
mammalian cells have previously been found to endocytose extracellular fluid and 
solutes at a slower rate than Dictyostelium cells (Thilo, 1985). Following incubation, cells 
were washed repeatedly and harvested with TrypsinIV ersene. They were then lysed and 
OPD (a colorimetric HRP substrate) was added. The absorbance was measured at 450 nm 
on a spectrophotometer. 
Concentration CM 25 % RBC lysate 
Sample (~M) Absorbance (450 nm) N Absorbance (450 nm) 
±SD ±SD 






20 1.2 ± 0.1 3 1.4±0.1 
20 1.2 ± 0.1 3 1.2±0.1 
20 0.6 ± 0.1 3 0.9 ± 0.1 
20 0.1 ± 0.0 3 0.4 ± 0.0 
20 0.8 ± 0.1 3 0.6 ± 0.1 
Table 7.1. The effect of anti-malarial drugs on HRP uptake and accumulation by A549 cells, 
measured as Absorbance (450 run) ± standard deviation (SD) of the cell lysates following the 
addition of an HRP subtrate. Cells were untreated (Control), or treated with 20 IlM amodiaquine 
(AQ), chloroquine (CQ), halofantrine (H), mefloquine (MQ) or quinine (Q) in complete medium 
(CM) or medium containing 25 % red blood cell (RBC) lysate for 150 minutes. N= sample size. 
It was found that A549 cells treated with 20 ).lM CQ for 150 minutes did not show a 
statistically significant change in HRP internalization relative to untreated control cells (P 
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a reduction in HRP uptake and accumulation relative to untreated controls (P = 0.0101, P 
= 0.004 and P = 0.0408 for H, MQ and Q respectively) (Table 7.1, Figure 7.1). As shown 
in Figure 7.1, the addition of RBC lysate to untreated control A549 cells did not result in 
a statistically significant change in HRP levels following a 150 minute incubation period 
(P = 0.4957, 95% CI). Cells treated with RBC lysate and CQ did not show a statistically 
significant change in HRP levels relative to cells treated with CQ alone (P = 0.5282, 95% 
CI). 
A549 cells that were treated with RBC lysate and H or MQ showed an increase in HRP 
accumulation relative to cells treated with H or MQ alone (P = 0.0178 and P = 0.0001 for 
Hand MQ respectively). Cells treated with RBC lysate and Q showed a reduction in HRP 
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Fig 7.1. The effect of the quinoline anti-malarial drugs on HRP uptake and accumulation by 
A549 cells. Cells were incubated with HRP and treated with 20 )lM amodiaquine (AQ), 
chloroquine (CQ), halofantrine (H), mefloquine (MQ) or quinine (Q) for 150 minutes. Cells were 
either incubated in complete medium (CM) or in medium containing 25 % red blood cell (REC) 
lysate. Following incubation, cells were washed, lysed, a colorimetric HRP subtrate was added. 
Absorbance was measured at 450 nm. Error bars indicate standard error. * Statistically significant 












Chapter 7 HRP Uptake and Accumulation in A549 Cells 
A549 cells that were treated with 20 IJ-M AQ for 150 minutes showed variable changes in 
HRP uptake accumulation. Figure 7.2 shows the HRP levels in cells treated with AQ on 4 
separate occasions. It was found that the addition of RBC lysate to untreated control cells 
did not result in a statistically significant change in HRP levels (P = 0.9994, 95 % CI). 
On day 1, AQ-treatment caused a reduction in HRP internalization relative to the 
untreated control cells (P = 0.0209). On day 2, cells treated with RBC lysate and AQ also 
showed a reduction in HRP levels relative to controls treated with RBC lysate alone (P = 
0.0025). However, on day 3 cells treated with AQ did not show a statistically significant 
change in HRP uptake relative to untreated control cells (P = 0.7976). On the same day, 
cells treated with AQ and RBC lysate showed an statistically significa t increase in HRP 
levels relative to cells treated with AQ alone (P = 0.0469). (Table 7.2) 
Concentration CM 25 % RBC lysate 
HRP Levels HRP Levels 






100.0±17.6 3 100.0 ± 5.4 
20 62.8 ± 7.1 3 
20 51.5 ± 2.5 
20 103.0 ± 9.2 3 123.4 ± 8.5 
20 86.9 ± 15.6 3 
Table 7.2. The effect of amodiaquine (AQ)-treatment on HRP uptake and accumulation by A549 
cells. Cells were untreated (Control), or treated with 20 )lM AQ on day 1 (AQ I), day 2 (AQ 2), 
day 3 (AQ 3) and day 4 (AQ 4). Cells were either incubated in complete medium (CM) or 
medium containing 25 % red blood cell (REC) lysate for 150 minutes. Cells were washed, lysed 
and a colorimetric HRP substrate was added. Absorbance readings (450 nm) were detennined 
using a spectrophotometer and then normalized to control readings (100 %) ± standard deviation 















Chapter 7 HRP Uptake and Accumulation in A549 Cells 
On day 4 AQ-treated cells showed a reduction in HRP internalization relative to 
untreated control cells, however the change was not statistically significant at the 95 % 












- 25 % RBC lysate 
Fig 7.2. The effect of amodiaquine (AQ) on HRP uptake and accumulation by A549 cells, 
measured as Absorbance (450 nm) of the cell lysates following the addition of an HRP subtrate. 
Cells were untreated (Control, Con), or treated with 20 11M AQ on day 1 (AQ 1), day 2 (AQ 2), 
day 3 (AQ 3) and day 4 (AQ 4). Cells were either incubated in complete medium (CM) or 
medium containing 25 % red blood cell (RBC) lysate for 150 minutes. N = sample size. 
Absorbance readings were normalized to control readings. Error bars indicate standard error. 
*Statistically significant change from the control (95% CI). # Statistically significant change from 
cells treated with drug alone. 
A549 cells were treated with lower concentrations of MQ in order to determine the 
minimum concentration of drug required to affect HRP uptake and accumulation and to 
compare the activity of MQ in these cells to D. discoideum and P. Jalciparum. It was 
found that MQ caused a significant reduction in levels of tracer enzyme following 
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Fig 7.3. The effect of increasing concentrations of mefloquine (MQ) on HRP uptake and 
accumulation by A549 cells. Cells were treated with 1.25 - 20 11M MQ for 150 minutes. Cells 
were washed, lysed and OPD (colorimetric HRP substrate) was added. Absorbance at 450 nm 
was measured using a spectrophotometer. Error bars indicate standard error. 
7.3 Discussion 
7.3.1 Chloroquine 
Although CQ has previously been shown to influence the secretory pathway in 
mammalian cells from concentrations of 100 11M (Schrader-Fischer and Paganetti, 1996; 
Davis and Mecham, 1998), the effect of the drug on the endocytic pathway in these cells 
has not been evaluated. Therefore, as results obtained in Chapter 6 suggest that CQ may 
disrupt the endolysosomal pathway in D. discoideum at a concentration of 20 11M, A549 
cells were treated the drug at this concentration. CQ was however not found to have a 
significant effect on HRP accumulation in A549 cells at this concentration. 
The presence of FP in compartments along the endocytic and secretory pathways may 
enable CQ to accumulate to a greater degree, resulting in disruption of trafficking and 
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membrane function has been found to be dependent on the presence of FP (Chou and 
Fitch, 1980; Chou and Fitch, 1981; Orj ih et ai, 1981; Fitch et ai, 1982; Fitch et ai, 1983). 
Therefore, RBC lysate was added in order to determine the effect of the presence of FP 
and/or hemoglobin on the potency of CQ action. It was found that the addition of RBC 
lysate resulted in a slight increase in HRP levels, however the change was not statistically 
significant at the 95% CI. FP may thus be required at a higher concentration than used in 
this experiment in order to substantially affect CQ accumulation and action, however the 
toxicity of FP may then influence the assay. 
7.3.2 l"Welfoquine and Halofantrine 
Treatment with 20 flM H or MQ for 150 minutes resulted in a reduction in HRP uptake 
and accumulation in A549 cells relative to untreated control cells. These drugs are thus 
likely to disrupt endocytosis and/or stimulate efflux from mammalian cells, as well as D. 
discoideum cells (Chapter 6) and P. Jalciparum parasites (Chapters 3-5). Therefore, as 
these drugs have been found to inhibit endocytosis and/or stimulate efflux in the cells of 
three diverse types of organisms at relatively low concentrations, it is likely that they 
have the same effect in a wide range of other organisms. These drugs may thus prove 
useful for cellular biological studies where specific inhibition of endocytosis is required. 
On the other hand, MQ was previously shown to bind to membranes and purified 
phospholipids with high affinity (Chevli and Fitch, 1982; San George et aI, 1984). 
Additionally, the drug has been found to inhibit the phagocytic activity of human 
polymorphonuclear neutrophils (Labro and Babin-Chevaye, 1988). These findings, along 
with the finding that MQ and H affect exocytosis in D. discoideum (Chapter 6), suggest 
that these drugs do not have a specific target, but rather that they disrupt membrane 
function non-specifically. Treatment of A549 cells with MQ was found to cause a 
reduction in HRP uptake and accumulation at concentrations of 10 flM or above. 
Therefore, the drug is unlikely to disrupt membrane function in mammalian cells at 
therapeutic or prophylactic concentrations. 
FP has been found to play an important role in CQ accumulation (Aikawa, 1972; Fitch et 
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disruption of membrane function (Chou and Fitch, 1980; Chou and Fitch, 1981; Orjih 
etal, 1981; Fitch et aI, 1982; Fitch et aI, 1983). As CQ is structurally related to MQ and 
H, the presence of FP in malarial parasites may also influence the mechanism(s) of action 
of these drugs. Therefore, A549 cells were treated with 20 11M H or MQ and RBC lysate 
for 150 minutes. The addition of RBC lysate was found to result in the accumulation of 
HRP to a greater extent than in cells treated with drug alone. It is possible that MQ and H 
bind to hemoglobin or FP and are sequestered away from their site of action, thus 
reducing their inhibitory effects on endocytosis. In support, MQ (Chou et aI, 1980; Chevli 
and Fitch, 1982) and H (Egan et aI, 1994; Basilico et aI, 1997; Hawley et aI, 1998; Egan 
et aI, 1999; Ursos et aI, 2001) were previously found to interact weakly with FP. 
7.3.3 Quinine 
Treatment of A549 cells with 20 11M Q for 150 minutes also caused a reduction in HRP 
accumulation relative to the controls, although to a lesser extent than in MQ or H-treated 
cells. This is consistent with the findings of uptake and accumulation assays conducted in 
D. discoideum, where Q was found to have little or no effect (Chapter 6). Treatment with 
Q and RBC lysate resulted in a further reduction in HRP levels, suggesting that FP has an 
adjuvant effect on Q action and that Q may inteact with FP to inhibit endocytosis to a 
greater extent. In SUppOlt, it has previously been found that Q does interact wealdy with 
FP (Chou et aI, 1980). 
7.3.4 Amodiaquine 
AQ-treatment was found to result in variable levels of hemoglobin accumulation in 
malarial parasites (Chapter 3). Additionally, treatment of D. discoideum with this drug 
resulted in inconsistent degrees of FITC-Dextran accumulation (Chapter 6). The same 
trend was observed in A549 cells following treatment with 20 11M AQ for 150 minutes. 
Levels of HRP accumulation were found to vary widely at different times. AQ-treatment 
is likely to result in the concurrent disruption of endocytosis, vesicular processing and 
docking in P. Jalciparum 3D7 (Chapters 3-5) and D. discoideum (Chapter 6). Therefore, 
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Chapter 6, the possible complexity and pleiotropy of AQ's effects means that AQ-
treatment may cause the inhibition of endocytosis and of vesicular processing and 
docking as well as exocytosis to variable degrees at different times, an effect that is not 
surprising given that living organisms are likely to respond to drug treatment in varying 
ways at different stages of growth or health. AQ may additionally influence the secretory 
pathway in these cells, as has previously been found in mammalian cells treated with CQ 
(Schrader-Fischer and Paganetti, 1996; Davis and Mecham, 1998). 
A549 cells were treated with AQ and RBC lysate in order to investigate the influence of 
the presence of hemoglobin and FP on AQ action. It was found on one occasion that cells 
treated with AQ and RBC lysate contained raised levels of HRP relative to cells treated 
with AQ alone. However, due to the variable changes in A549 cellular reponses to AQ-
treatment, it is difficult to draw any conclusions regarding the effect of the treatment with 
AQ in the presence of RBC lysate. In support, on another occasion, it was found that 
treatment with AQ and RBC lysate caused a large reduction in intracellular HRP levels 
relative to cells treated with RBC lysate alone. Therefore, numerous additional assays 
would be required in order to draw any sound conclusions regarding the effect of the 






























Chapter 8 Summary and Conclusion 
pathway or hemoglobin digestion may be inhibited. Food vacuoles were however 
normal in size, in contradiction to previous reports (Macomber and Sprinz, 1967; 
Warhurst and Hockley, 1967; Aikawa, 1972). Hemoglobin levels were found to be 
largely increased in parasites treated with CQ in Western Blotting assays (Chapter 3), 
as previously found (Famin and Ginsburg, 2002; Fitch et ai, 2003a; Hoppe et ai , 
2004). Additionally, in an immunofluorescence assay (Chapter 5) it was found that 
the numbers of hemoglobin transport vesicles in the parasite cytoplasm were raised in 
CQ-treated parasites relative to those in untreated parasites [as found by Hoppe et al 
(2004)] , while parasite food vacuoles contained normal levels of hemoglobin. 
Treatment with CQ has previously been found to inhibit the processing of hemoglobin 
transport vesicles (Macomber et ai, 1967; Warhurst and Hockley, 1967; Fitch et ai, 
2003a), causing their accumulation in either the food vacuole in some strains (Yayon 
et ai , 1984), or the cytoplasm in other strains (Fitch et ai, 2003a; Hoppe et ai, 2004). 
The varying results of these studies suggest that the cell biological responses of 
malarial parasites to CQ-treatment may be species and strain dependent. The findings 
of this study as well as of previous studies, suggest that CQ may disrupt the 
endolysosomal pathway in malarial parasites, either causing or as a result of the 
inhibition of hemoglobin digestion, as previously suggested (Famin and Ginsburg, 
2002). 
CQ is a weak base that accumulates in the parasite food vacuole by an ion-trapping 
mechanism or by its high affinity binding to FP (Aikawa, 1972; Fitch et ai, 1974; 
Krogstad et ai, 1985; Hawley et ai, 1996). CQ may then inhibit vesicular docking and 
fusion at the food vacuole in strain 3D7 parasites by causing the pH to rise in this 
organelle (Krogstad et ai, 1985) or by interacting with membranes through an FP 
bridge and disrupting their function [as suggested by Hoppe et al (2004) and Fitch 
(2004)]. CQ has been found to slow the rate of FP dimerization (Egan and Ncokazi, 
2005), causing it to accumulate (Chou and Fitch, 1993 ; Zhang et ai, 1999; Famin and 
Ginsburg, 2002). Build-up of this toxic molecule may cause the disruption of 
membrane function (Chou and Fitch, 1980; Chou and Fitch, 1981; Orjih et ai, 1981; 
Fitch et ai, 1982; Fitch et ai, 1983), inhibiting vesicular docking as a consequence. 
Additionally, high levels of FP may inhibit the proteolytic enzymes (Tappel, 1955; 
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Chapter 8 Summary and Conclusion 
along the endolysosomal pathway in malarial parasites enables CQ to accumulate to a 
higher concentration (Aikawa, 1972; Fitch et aI, 1974; Krogstad et aI, 1985; Hawley 
et aI, 1996) and disrupt vesicular processing when added at lower concentrations. 
Therefore, in mammalian cells (and in D. discoideum cells) in the absence of FP, 
treatment with CQ at higher concentrations appears to be necessary to effectively 
disrupt the endolysosomal system. A549 cells were incubated with CQ and RBC 
lysate which contained large amounts of hemoglobin in order to determine whether 
the presence of FP would amplify the effect of CQ. However, it was found that the 
addition of RBC lysate did not cause a significant change in HRP uptake and 
accumulation. It can thus be hypothesized that, either hemoglobin remains undigested 
in these cells and FP is thus not released, or that FP is not present at a high enough 
concentration to affect CQ accumulation and/or action. Conducting experiments using 
pure FP or RBC lysate at a higher concentration could pr ve inconclusive as the 
toxicity of FP may substantially influence the assay. 
8.2 Mejloquine, Halofantrine and Quinine 
Due to the structural similarity of MQ, Hand Q, it has been hypothesized that the 
modes of action of these drugs are similar. MQ has previously been found to inhibit 
endocytosis in strain D lOP. Jalciparum (Hoppe et aI, 2004), while it has been 
suggested that Q has the same effect (Famin et aI, 1999; Famin and Ginsburg, 2002). 
MQ, Hand Q were indeed found to act similarly and inhibit endocytosis in strain 3D7 
P. jalciparum. Parasites that were treated with these drugs for 8 hours and observed 
under a light microscope following Giemsa staining were reduced in size relative to 
untreated parasites (Chapter 2). Additionally, parasite food vacuoles and hemozoin 
crystals were barely visible, if at all, suggesting that either endocytosis is inhibited or 
that hemoglobin digestion is disrupted. In a Western Blotting assay (Chapter 3), it was 
found that treatment of parasites with MQ, H or Q each caused a reduction in 
hemoglobin levels relative to untreated parasites. Likewise, MQ (Famin and 
Ginsburg, 2002; Hoppe et aI, 2004) and Q-treatment (Famin et aI, 1999; Famin and 
Ginsburg, 2002) have previously been shown to have this effect on parasite 
hemoglobin levels. MQ, Hand Q were additionally found to cause a reduction in 
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with PIs alone (Chapter 3), suggesting that hemoglobin reduction in parasites treated 
with these drugs is independent of the digestion of this protein. In support, MQ has 
previously been found to have no effect on hemoglobin degradation (Famin and 
Ginsburg, 2002). In an HRP internalization assay (Chapter 4), it was found that 
treatment with MQ, H or Q caused a reduction in HRP uptake and accumulation. 
Furthermore, in an Immunofluorescence assay (Chapter 5) it was found that the 
numbers of hemoglobin transport vesicles in the parasite cytoplasm, as well as the 
levels of hemoglobin in parasite food vacuoles, were reduced in comparison to 
untreated parasites. 
The effects of MQ, Hand Q on endocytosis and exocytosis in D. discoideum were 
evaluated in an FITC-Dextran uptake assay (Chapter 6). It was found that treatment 
with increasing concentrations of MQ and H caused a large reduction in tracer 
molecule uptake and accumulation. Therefore, these drugs may also inhibit 
endocytosis in D. discoideum. MQ and H were additionally found to inhibit 
endocytosis at lower concentrations than drugs, such as vanadate, caffeine (Brenot et 
aI, 1992) and cisplatin (Reddy and Chatterjee, 1997), which are normally used to 
inhibit this process in Dictyostelium. Treatment with Q, however, only resulted in a 
small decrease in tracer molecule levels relative to untreated cells. In order to 
determine the contribution of exocytosis to reduced FITC-Dextran levels in D. 
discoideum cells following treatment with these drugs, an exocytosis assay was 
conducted. It was found that treatment with 20 )lM MQ, H or Q caused FITC-Dextran 
efflux from Dictyostelium cells. This suggests that the drugs may stimulate the 
secretory pathway in D. discoideum and that this may partially account for the 
reduction in intracellular tracer molecule levels observed in the previous assay, as 
well as the reduction in hemoglobin levels observed in 3D7 P. Jalciparum parasites 
following treatment with these drugs. Numbers of hemoglobin transport vesicles in 
parasites treated with MQ, H or Q were found to be reduced (Chapter 5). Therefore, 
the reduction in hemoglobin levels (Chapter 3) and HRP levels (Chapter 4) observed 
in 3D7 parasites treated with MQ, H or Q are likely to be primarily due to inhibition 
of endocytosis, rather than stimulation of hemoglobin efflux from the cell. One would 
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reduced hemoglobin or HRP levels. Therefore protein efflux is likely to only partially 
(at most) contribute to reducing these levels in P. Jalciparum. 
In order to detennine whether MQ, H and perhaps Q have similar effects in the cells 
of other organisms, an HRP uptake assay was conducted using mammalian A549 cells 
(Chapter 7). It was found that treatment with 20 )lM MQ, Hand Q all caused a 
reduction in tracer molecule accumulation, although Q had a lesser effect than the 
other drugs. Therefore, MQ and H appear to inhibit endocytosis in mammalian cells, 
as well as in P. Jalciparum and D. discoideum. MQ and H may inhibit endocytosis in 
a wide range of organisms and may therefore prove valuable for cell biological 
studies in which the inhibition of this process is specifically required. However, as 
MQ has previously been found to bind to purified phospholipids with high affinity 
(Chevli and Fitch, 1982; San George et aI, 1984), MQ and H may disrupt membrane 
function non-specifically. In support, MQ has been found to inhibit phagocytic 
activity in human immune cells (Labre and Babin-Chevaye, 1988). Additionally, MQ 
and H were found to influence exocytosis in D. discoideum cells (Chapter 6). In order 
to detennine the sensitivity of A549 cells to MQ relative to D. discoideum and P. 
Jalciparum 3D7 and to evaluate the possibility of side effects during anti-malarial-
treatment, A549 cells were incubated with lower concentrations of the drug. It was 
found that MQ inhibited endocytosis in A549 cells from a concentration of 10 )lM. It 
is thus unlikely that these drugs influence membrane function in mammalian cells at 
malarial prophylactic or therapeutic concentrations. 
FP has previously been found to play an important role in CQ accumulation (Aikawa, 
1972; Fitch et aI, 1974; Krogstad et aI, 1985; Hawley et aI, 1996) and possibly CQ 
disruption of membrane function (Fitch, 2004; Hoppe et aI, 2004) in malarial 
parasites. Therefore, FP may influence the action of other quinoline anti-malarials, as 
these drugs are structurally related. A549 cells were incubated with MQ, H or Q and 
25% red blood cell (RBC) lysate. Treatment with MQ or H in the presence of RBC 
lysate was found to result in less of a reduction in HRP accumulation than observed in 
cells treated with drug alone. It can thus be suggested that these drugs bind to 
hemoglobin or FP and are sequestered away from their site of action. In support, MQ 
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1997; Hawley et aI, 1998; Egan et aI, 1999; Ursos et aI, 2001) were previously found 
to interact weakly with FP. Treatment with Q and RBC lysate resulted in a further 
reduction in HRP levels relative to cells treated with Q alone. Therefore, the activity 
of Q appears to be enhanced by the presence of hemoglobin or FP. Q has previously 
been found to interact with FP (Chou et aI, 1980). 
8.3 Amodiaquine 
AQ may inhibit endocytosis in 3D7 P. Jalciparum cells, while concurrently inhibiting 
vesicular processing and hemoglobin digestion. Parasites that were treated with AQ 
for 8 hours and stained with Giemsa were found to be variably smaller and larger than 
untreated parasites (Chapter 2), suggesting that the effects of the drug may be 
intermediate, or a combination of MQ and CQ-type modalities. The effects of AQ are 
furthermore likely to be stage-specific. In Western Blotting assays (Chapter 3), AQ-
treated parasites either showed a slight reduction in hemoglobin levels or no change 
relative to the controls, while in an HRP intern lization assay, parasites treated with 
AQ accumulated less HRP relative to untreated parasites (Chapter 4). The finding that 
AQ inhibited HRP internalization, but did not cause a large reduction in hemoglobin 
levels in parasites suggests that both endocytosis and hemoglobin digestion are 
inhibited by the drug. Hemoglobin levels in AQ-treated parasites were found to vary, 
implying that the predominant effect of AQ may fluctuate between the inhibition of 
endocytosis and the inhibition of hemoglobin digestion. This observation is not 
surprising given that living organisms are likely to respond to drug treatment in 
different ways at different stages of growth or health. 
Immunofluorescence assays were conducted in order to shed further light on the 
precise nature of the effect of AQ on the endolysosomal pathway in malarial parasites 
(Chapter 5). The findings of these assays provided support for the hypothesis that AQ 
concurrently inhibits endocytosis, vesicular docking and hemoglobin digestion. As 
observed in CQ-treated parasites, hemoglobin transport vesicles were found to 
accumulate in parasites treated with AQ, although to a lesser extent. It can thus be 
deduced that treatment with AQ may result in a build-up of transport vesicles by 
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AQ may have the same effect in D. discoideum amoeboid cells. AQ-treatment for 90 
minutes was found to cause variable changes in FITC-Dextran uptake and 
accumulation (Chapter 6). Levels of tracer molecules were sometimes reduced, but 
raised at other times. Intracellular FITC-Dextran levels reflect endocytosis, vesicular 
trafficking, processing and docking, as well as exocytosis. Therefore, as may be 
thecase in P. Jalciparum, AQ may inhibit endocytosis and concurrently disrupt 
vesicular processing to variable degrees at different times. Additionally, as CQ has 
been hypothesized to disrupt the secretory pathway in Dictyostelium due to its effect 
in mammalian cells (Smith et ai, 1982; Moore et ai, 1983; Schrader-Fischer and 
Paganetti, 1996; Davis and Mecham, 1998), AQ may also influence this pathway in 
D. discoideum cells. It was found in an exocytosis assay that treatment with AQ did 
not cause a change in FITC-Dextran secretion from D. discoideum cells (Chapter 6). 
This finding supports the hypothesis that treatment with AQ results in the concurrent 
inhibition of endocytosis and vesicular docking and/or exocytosis, as these cells 
would retain the tracer molecule. 
As the endolysosomal pathway is well understood in mammalian cells, HRP 
internalization assays were conducted using A549 cells in order to further evaluate the 
mode of action of AQ. The drug again caused variable changes in tracer molecule 
uptake and accumulation in these cells. This further implies that the predominant 
effect of AQ in drug-treated cells may fluctuate between the inhibition of endocytosis 
and the inhibition of vesicular processing and docking and/or secretion. The findings 
that the effects of AQ appear to be non-specific in the cells of individual organisms, 
but also that the drug affects three diverse types of organisms in a similar way, 
indicates that the drug is likely to non-specifically disrupt membrane function. Given 
the pleiotropy of A549 cellular reponses to AQ-treatment, it is difficult to draw any 
conclusions regarding the effect of treatment with AQ in the presence of RBC lysate. 
On one occasion, cells treated with AQ and RBC lysate were found to cause an 
increase in HRP accumulation relative to cells treated with AQ alone. However, on 
another occasion, cells that were treated with AQ and RBC lysate caused a large 
reduction in HRP levels relative to cells treated with RBC lysate alone. Therefore, 
numerous additional assays would be required in order to draw any sound conclusions 
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in A549 cells, and hence the importance of the presence of FP and/or hemoglobin on 
the mode of action of this drug in P. jalciparum. 
8.4 Conclusion 
The effects of the quinoline anti-malarials have been found to be pleiotropic in 
different strains of P. jalciparum and in parasites at various stages of growth. It is thus 
difficult to distinguish between the secondary and primary mechanisms of action of 
these drugs. Quinoline anti-malarials have been found to influence the endolysosomal 
pathway in malarial parasites. As this process is poorly understood, the difficulty in 
determining their precise mode of action if further confounded. A number of 
conclusions can however be drawn using the data generated during this study and that 
of previous studies. Treatment with CQ caused hemoglobin accumulation in 3D7 
parasites by either disrupting enzymatic function or inhibiting vesicular processing 
and resulting in the inhibition of hemoglobin digestion, and/or by disrupting the 
secretory pathway. Additionally, it was found that CQ may inhibit endocytosis to a 
small extent following a long incubation period. Furthermore, the drug appears to 
disrupt vesicular processing and/or secretion in D. discoideum. AQ may non-
specifically disrupt membrane function in P. jalciparum, D. discoideum and A549 
cells, inhibiting endocytosis, vesicular docking and/or exocytosis concurrently. It was 
also found that the action of this drug may be largely stage-specific. MQ and H were 
found to inhibit endocytosis and/or possibly slightly stimulate exocytosis in P. 
jalciparum, D. discoideum and A549 cells. It was shown that Q inhibited endocytosis 
and/or stimulated exocytosis in P. jalciparum and A549 cells. However, the drug 
appeared to affect exocytosis alone in D. discoideum. 
Therefore the quinoline anti-malarials, MQ and H in particular, are likely to prove 
useful for further study of the endocytic pathway in malarial parasites and other 
organisms. A better understanding of this essential process may prove useful for 
future drug discovery. Additionally, as the quinoline anti-malarials have been found 
to influence the endolysosomal pathway, these drugs may be used in combination 













Materials and Methodology 
9.1 Cell Culture and Maintenance 
9.1.1 Plasmodium Jalciparum 
The 3D7 strain of P. Jalciparum was maintained in 4 % (vol/vol) 0+ human red blood 
cells (RBCs) and RPMI 1640 medium supplemented with 50 mM glucose, 25 mM 
HEPES, 0.65 mM hypoxanthine, 0.048 mglml gentamycin, 0.5 % (wtlvol) Albumax II, 
and 0.2 % (wtlvol) Sodium Bicarbonate (NaHC03). The cultures were stored in 50 ml 
culture flasks and incubated at 37°C under a gas mixture of 4 % CO2, 3 % O2, 93 % N2. 
The cultures were synchronized using the sorbitol method (Lambros and Vanderberg, 
1979). The parasites were viewed by oil immersion light microscopy using Giemsa-
stained blood smears. The parasitaemia was calculated by counting the number of 
parasites relative to the number of RBCs. 
9.1.2 Dictyostelium discoideum 
The axenic strain of D. discoideum (Ax2) was maintained in HL5 medium at 22°C in 
suspension in flasks shaken at 150 rpm (Watts and Ashworth, 1970). 
9.1.3 A549 Cells 
A549 cells, established in permanent culture from a human lung adenocarcinoma (Lieber 
et aI., 1976), were cultured in Dulbeco's modified Eagle medium (DMEM, 4.5 giL 
Glucose and L-Glutamine; Bio Whittaker), supplemented with 10 % heat inactivated fetal 
calf serum (FCS) and 1 % L-Glutamine, In the presence of % 
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atmosphere. Cells were harvested by addition of TrypsiniV ersene (0.25 % trypsin, 0.1 % 
versene EDT A in PBS; Highveld Biological) and incubation for 10 minutes at 37°C. 
9.2 Parasite Lactate Dehydrogenase Assay 
The assay was performed in 96-well rnicrotitre plates. The blank for the assay was 
unparasitised RBCs without drug and the control was parasitized RBCs (PRBCs) without 
drug. The final haematocrit in each well was 1 % and the final parasitaemia was 2 %. 
Each drug was two-fold serially diluted in triplicate. The final volume in each well was 
200 ).11. Plates were incubated for 48 hours at 37°C in desiccator cabinets under 4 % CO2, 
3 % O2, 93 % N2• 
Following incubation, 100 ).11 Malstat reagent and 25 ).11 NBT/PES were added to the 
wells of a separate 96-well microtitre plate. Malstat reagent consists of lactate (substrate), 
APAD+ (cofactor), Triton X-I 00 (membrane detergent), and HEPES (buffer). NBT/PES 
contains equal volumes of nitroblue tetrazolium (1.6 mg/ml) and phenazine ethosulfate 
(0.08 mg/mI). The parasite cultures were resuspended and 15 III from each well was 
added to the corresponding well of the duplicate plate. The plates were read at a 
wavelength of 620 nm in a scanning multiwell spectrophotometer (ELISA reader). 
9.3 P. Jalciparum Drug Treatments 
9.3.1 Western Blot and Immunofluorescence Assays 
Drugs were added to the parasite cultures at concentrations approximately 5 times the 
ICso values of each drug: 137 nM CQ; 156 nM MQ; 665 nM Q; 102 nM AQ; 27 nM H. 
The drugs were added in triplicate to 2 ml cultures in 24-well plates. The cultures were 
used at 10-20 % parasitaemia, 1 % haematocrit, with parasites in the early trophozoite 
stage. The plates were placed in desiccator chambers and incubated for 6 to 8 hours at 37 
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9.S P. Jalciparum Immunofluorescence Assay 
pRBCs from 2 ml cultures were pelleted by centrifugation at 2000 ref for 3 minutes in a 
microcentrifuge. The pellets were resuspended in 1 ml of 0.25 % saponin in PBS to lyse 
the RBC membranes. The released parasites were pelleted by centrifugation at 3300 ref 
for 3 minutes. The parasites were washed 4-5 times in cold PBS and resuspended in 1 ml 
PBS. Glass coverslips were incubated in poly-L-lysine for 15 minutes and placed in a 24-
well plate. They were washed 4 times with PBS and left in 1ml PBS. 500 fll aliquots of 
the parasite suspensions were added to the wells. The parasites were then pelleted onto 
the coverslips by centrifugation at 99 ref for 2 minutes and the coverslips were washed 4 
times with PBS. The covers lips were fixed with 500 ).11 4 % (wtlvol) paraformaldehydel 
0.25 % gluteraldehyde for 15 minutes. They were then washed 4 times with PBS and 
incubated in 500 fll 0.5 % triton for 5 minutes. The coverslips were washed 4 times with 
PBS and then incubated in 500 fll 0.15 M glycine for 20 minutes. They were washed 4 
times in PBS and then incubated in blocking solution (PBS containing 1mM CaCh, 1mM 
MgCh, 2 % [wtlvol] bovine serum albumin [BSA], 10 % [vol/vol] fetal calf serum, and 
0.1 % [vol/vol] Tween 20) for 30 minutes. The covers lips were then incubated in 
blocking solution containing rabbit anti-hemoglobin antiserum (1 :200) for 1 hour. They 
were then washed 4 times with wash medium (PBS containing 0.1 % [wt/vol] BSA and 
0.1 % [vol/vol] Tween 20) and incubated in blocking solution containing rhodamine-
conjugated goat anti-rabbit IgG (1 :250) (Invitrogen) for 1 hour in the dark. All 
subsequent steps were conducted in the dark. Following incubation, the coverslips were 
washed 4 times with wash medium and once with PBS. They were then dipped in PBS 
containing DAPI (1 mg/ml), rinsed in water and drained. The coverslips were mounted in 
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9.6.4 HRP Endocytosis Assay 
pRBCs from 2 ml cultures were pelleted by centrifugation at 2000 rcf for 3 minutes in a 
microcentrifuge. The pellets were resuspended in 1 ml of 0.25 % saponin PBS to lyse the 
RBC membranes. The released parasites were pelleted by centrifugation at 3300 rcf for 3 
minutes. The parasites were washed 4-5 times in cold PBS and lysed with 1 ml 1 % 
Triton in 0.1 M phosphate citrate buffer (PH 4.8). Samples were then centrifuged at 3300 
rcf for 3 minutes in order to pellet hemazoin crystals. 100 III aliquots of each sample were 
added to 100 III aliquots of 6 mg/ml o-phenylenediamine (OPD, colorimetric HRP 
substrate; Sigma Aldrich) and 0.2 % H20 2 in phosphate citrate buffer. Absorbance was 
measured at a wavelength of 450 run in a scanning multiwell spectrophotometer (ELISA 
reader). 
9.7 D. discoideum Fluid-Phase Endocytosis Assay 
FITC-Dextran (average molecular weight, 70 000) from Sigma Aldrich was used as a 
fluid-phase marker (Thilo and Vogal, 1980). Amoeboid cells were suspended at a 
concentration of 3 x 106 cells/ml in HL5 medium containing 2 mg/ml FITC-Dextran (Lim 
et ai, 2005). Cells were incubated in triplicate with increasing concentrations of AQ, CQ, 
H, MQ and Q for 90 minutes at 22°C. Cells were incubated for a short period of time 
relative to P. Jalciparum experiments due to the rapid rate of endocytosis in D. 
discoideum. 150 III aliquots were then removed from all cultures. FITC-Dextran was 
added to control aliquots, followed immediately by 1 m! ice-cold 20 mM potassium 
phosphate buffer (KH2P04 , pH 6.0), in order to stop the reaction (Shanna et ai, 2002). 
KH2P04 was added to the remaining aliquots and the samples were centrifuged at 2000 
rcf for 3 minutes. The pellets were then washed three times. Cells were either were fixed 
with 4% parafonnaldehyde (PFA) for 5 minutes (Ravanel et ai, 2001) or lysed with 100 
III 6.25 % Triton X-100. Fixed cells were washed with KH2P04 and mounted under a 
coverslip in anti-fading polyvinyl alcohol mounting medium for viewing under a 
fluorescence microscope. 900 III 50 mM sodium phosphate buffer (Na2HP04 , pH 9.2) 
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Na2HP04 and were read on a fluorescence spectrophotometer (excitation 470 nm; 
emission, 520 nm) (Reddy and ChatteIjee, 1997). 
9.8 D. discoideum Fluid-Phase Exocytosis Assay 
FITC-Dextran was used as a fluid-phase marker (Thilo and Vogal, 1980). Amoeboid cells 
were suspended at a concentration of 3 x 106 cells/ml in HL5 medium containing 2 
mg/ml FITC-Dextran (Lim et aI, 2005), and allowed to take up tracer molecule for 90 
minutes at 22°C. The cells were then washed twice with HL5 medium and 20 11M of 
each drug was added. The cultures were incubated for a further 60 minutes and 90 
minutes at 22°C. 150 III aliquots were then removed and centrifuged at 3300 ref for 3 
minutes. 100 III aliquots of the supernatant was retrieved from each sample and added to 
900 III Na2HP04. Samples were read on a fluorescence spectrophotometer (excitation 470 
nm; emission, 520 nm). 
9.9 A549 HRP Endocytosis Assay 
Cells were allowed to attach to the surface of the wells in 24 well plates for 24 hours. 
Fresh medium containing 20 11M of each drug and 0.5 mg/ml HRP was added and 
cultures were incubated at 37°C in a 5 % CO2 atmosphere for 150 minutes. Cells were 
then washed 3 times with PBS and harvested with TrypsinlVersene. Samples were 
centrifuged at 2000 ref for 3 minutes and again washed with PBS. Cells were lysed with 
250 III aliquots of 10 % triton in 0.1 M phosphate citrate buffer (PH 4.8). 100 III aliquots 
of each sample were then added to 100 III 6 mg/ml OPD (HRP colorimetric substrate) 
and 0.2 % H20 2 in phosphate citrate buffer. Absorbance was measured at a wavelength of 
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